Tanzanian Bark Herb

Enantia chlorantha contains isoquinoline alkaloids, primarily berberine, palmatine, columbamine, and jatrorrhizine, which are responsible for its therapeutic effects. These compounds demonstrate antimalarial activity by interfering with parasite DNA replication and inhibiting heme polymerization within malaria parasites. The alkaloids also exhibit hepatoprotective properties through antioxidant mechanisms that support liver function. Additionally, the bitter compounds stimulate digestive secretions, explaining its traditional use as a digestive bitter. Evidence level: C.

Enantia chlorantha may interact with medications metabolized by the liver, particularly cytochrome P450 substrates, due to its berberine and palmatine content. It may enhance the effects of antidiabetic medications and anticoagulants, potentially causing hypoglycemia or increased bleeding risk. The herb should not be combined with prescription antimalarials without medical supervision. Patients taking immunosuppressants or hepatotoxic medications should avoid this herb. Always consult a healthcare provider before combining with prescription medications. Evidence level: C/Traditional.

The typical adult dosage for Enantia chlorantha is 200-400mg of standardized alkaloid extract daily, traditionally prepared as a decoction of the bitter bark. Dosage may vary depending on the preparation method and concentration of active compounds. Standardized extracts ensure consistent berberine and palmatine content for therapeutic effect. Due to limited clinical studies establishing optimal dosing, individuals should follow manufacturer guidelines or consult a qualified herbalist for personalized recommendations. Evidence level: C/Traditional.

Enantia chlorantha is contraindicated during pregnancy and breastfeeding. The berberine content can stimulate uterine contractions and may cross the placenta, potentially harming fetal development. Traditional use and pharmacological evidence indicate this herb should be strictly avoided by pregnant women. Additionally, the alkaloids may be excreted in breast milk and affect nursing infants. Women of childbearing age should use reliable contraception while taking this herb. Evidence level: C/Traditional.

Enantia chlorantha, known as Tanzanian bark, has been used traditionally in East African medicine for treating malaria, fever, and liver conditions. The bitter bark is prepared as a decoction to reduce fever and support hepatic function. It serves as a digestive bitter to stimulate appetite and improve digestion. Traditional healers also use it for jaundice and other hepatic complaints. Modern research supports some antimicrobial and hepatoprotective properties, though clinical evidence remains limited. Evidence level: C/Traditional.

Common side effects of Enantia chlorantha include gastrointestinal upset, nausea, and abdominal discomfort due to its bitter alkaloid content. These effects are typically mild and dose-dependent. The herb may cause liver strain in individuals with pre-existing liver disease and is contraindicated in such cases. Prolonged use or excessive doses may lead to more serious adverse effects. Discontinue use if severe symptoms occur and consult a healthcare provider. Evidence level: C/Traditional.